<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A"><gtr:id>2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A</gtr:id><gtr:name>Missouri University of Science and Tech</gtr:name><gtr:address><gtr:line1>Missouri University of Science and Tech</gtr:line1><gtr:line2>1870 Miner Circle</gtr:line2><gtr:line4>Rolla</gtr:line4><gtr:line5>Missouri</gtr:line5><gtr:postCode>MO 65409</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/861A1F8D-B7F5-412C-8C6B-130B92E26B94"><gtr:id>861A1F8D-B7F5-412C-8C6B-130B92E26B94</gtr:id><gtr:firstName>Ferina</gtr:firstName><gtr:surname>Ismail</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6471"><gtr:id>3A6D40E7-9ADE-49F9-A58E-1E0EBEF667A7</gtr:id><gtr:title>Human papillomavirus associated anti-apoptotic mechanisms in the pathogenesis of non-melanoma skin cancer.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6471</gtr:grantReference><gtr:abstractText>Skin cancer is the commonest human cancer. An estimated 100,000 new cases of non-melanoma skin cancer (NMSC) are diagnosed each year in the UK, the incidence is doubling each decade and patients with deficient immune systems (such as organ transplant recipients) are at enormously increased risk. Exposure to ultraviolet radiation (UVR) is an important cause of NMSC, but there is evidence that human papillomaviruses (HPVs), some of which cause cervical cancer, may also play a part. The E6 protein of HPV appears to interact with UVR to prevent apoptosis - a form of cell death which prevents cells mutated by UVR from surviving and causing cancer. The aim of this project is to investigate the precise mechanisms by which E6 prevents apoptosis caused by UVR.

NMSC represents a major burden on public health and healthcare resources. This project will provide a clearer understanding of the role of HPV in NMSC. Not only may such new information provide novel targets for treating this common cancer and its precursors, but the recent successful introduction of preventative vaccines for anogenital HPV infection raises the possibility of future vaccination for high-risk individuals against NMSC if an important cofactor role for HPV is confirmed.</gtr:abstractText><gtr:technicalSummary>Non-melanoma skin cancer (NMSC) is the most commonly diagnosed cancer in the U.K, and its incidence is rising dramatically. Ultraviolet radiation (UVR) is critical to the pathogenesis of these tumours, but there is increasing evidence that human papillomavirus (HPV) infection plays a key role in promoting skin tumour development in cooperation with mutagenic effects of UVR. The Centre for Cutaneous Research has been at the forefront of research in this field. In recent years they, and others, have detected a high prevalence of HPV DNA in NMSCs, particularly from immunosuppressed individuals who are at 100-fold increased risk for skin cancer. In addition, they have preliminary evidence that HPV E6 proteins play an anti-apoptotic role in the epidermis by promoting proteolysis of the cellular anti-apoptotic protein, Bak. The hypothesis directing the proposed study is that HPV E6 proteins interfere with regulation of UV-induced apoptosis via inhibitory effects on Bak and/or other cellular pro-apoptotic proteins. 

In order to examine this hypothesis in vivo, I will use tumours collected from immunosuppressed and immunocompetent adults which have been HPV genotyped using a degenerate PCR/direct sequencing methodology. I will correlate tumour HPV status with apoptotic and proliferative rates by immunocytochemical and TUNEL analysis. I will then establish the expression and localisation of pro-apoptotic proteins by immunocytochemistry, focusing on Bak and Fas pathways which are known to participate in UVR-induced keratinocyte apoptosis. I will determine the impact of viral location, gene expression and copy number on these markers of proliferation and apoptosis by serial analysis of in situ PCR/DNA hybridisation, in situ reverse transcriptase PCR/RNA hybridisation, and quantitative real time PCR respectively. In parallel in vitro experiments, I will focus on interactions of HPV E6 proteins with mitochondrial apoptotic pathways. I will determine whether keratinocyte cultures expressing retrovirally-transduced HPV E6 proteins are able to inhibit mitochondrial release of cytochrome c and non-caspase dependent apoptotic proteins following induction of apoptosis by UVB. I will test whether this is Bak-dependent by small inhibitory RNA ?knockdown? experiments. In addition, I will investigate the role of the p53 codon 72 polymorphism on HPV associated anti-apoptotic effects in p53-null keratinocyte lines. Novel mechanisms further identified in vitro will be re-examined in tumour tissue. 

In summary, the proposed study will increase knowledge of the role of HPV in the molecular pathogenesis of NMSC and will provide a first-class training in modern approaches to the molecular understanding of cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-08-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>165828</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1B182202-8578-4F49-A934-B56B4BF55E87</gtr:id><gtr:title>Tyrosine dephosphorylation is required for Bak activation in apoptosis.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dc434bc39e6e38d9509fbfbc1ffeb96"><gtr:id>9dc434bc39e6e38d9509fbfbc1ffeb96</gtr:id><gtr:otherNames>Fox JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>Cvdi6GHN45X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ECD3F9E-33D0-4704-A268-9BBE144B7D5D</gtr:id><gtr:title>&amp;quot;Licensed to kill&amp;quot;: tyrosine dephosphorylation and Bak activation.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd93323ca1f87347a200b0499bfb0deb"><gtr:id>bd93323ca1f87347a200b0499bfb0deb</gtr:id><gtr:otherNames>Fox J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>bELtVkpHKEK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F09FAD28-EF27-46F1-8651-9FC58244A6EF</gtr:id><gtr:title>Cutaneous squamous cell carcinoma (SCC) and the DNA damage response: pATM expression patterns in pre-malignant and malignant keratinocyte skin lesions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/585e984ae1363063e9f21bb480b99ab3"><gtr:id>585e984ae1363063e9f21bb480b99ab3</gtr:id><gtr:otherNames>Ismail F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>LwaaNqRH6k9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6471</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>